NESS-0327

CAS No. 494844-07-4

NESS-0327( NESS 0327 | NESS0327 )

Catalog No. M14656 CAS No. 494844-07-4

A potent, selective CB1 cannabinoid receptor antagonist with Ki of 350 fM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 110 In Stock
10MG 188 In Stock
25MG 428 In Stock
50MG 719 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    NESS-0327
  • Note
    Research use only, not for human use.
  • Brief Description
    A potent, selective CB1 cannabinoid receptor antagonist with Ki of 350 fM.
  • Description
    A potent, selective CB1 cannabinoid receptor antagonist with Ki of 350 fM, >60,000-fold selective for the CB1 receptor versus CB2 receptor (Ki=21 nM); antagonizes WIN 55,212-2-stimulated [35S]GTPgammaS binding, antagonizes the inhibitory effects of WIN 55,212-2 on electrically evoked contractions in mouse isolated vas deferens preparations with pA2 12.46; inhibits the antinociceptive effect produced by WIN 55,212-2 (2 mg/kg s.c.) in both tail-flick (ID50=0.042 mg/kg i.p.) and hot-plate test (ID50=0.018 mg/kg i.p.).
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    NESS 0327 | NESS0327
  • Pathway
    GPCR/G Protein
  • Target
    Cannabinoid Receptor
  • Recptor
    Cannabinoid Receptor
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    494844-07-4
  • Formula Weight
    489.8
  • Molecular Formula
    C24H23Cl3N4O
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 9.7 mg/mL (19.80 mM)
  • SMILES
    O=C(C1=NN(C2=CC=C(Cl)C=C2Cl)C3=C1CCCC4=CC(Cl)=CC=C43)NN5CCCCC5
  • Chemical Name
    N-piperidinyl-[8-chloro-1-(2,4-dichlorophenyl)-1,4,5,6-tetrahydrobenzo [6,7]cyclohepta[1,2-c]pyrazole-3-carboxamide

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Ruiu S, et al. J Pharmacol Exp Ther. 2003 Jul;306(1):363-70. 2. Tambaro S, et al. Eur J Pharmacol. 2005 Nov 21;525(1-3):150-3. 3. Murineddu G, et al. J Med Chem. 2005 Nov 17;48(23):7351-62.
molnova catalog
related products
  • Otenabant

    A potent, and selective CB1 receptor antagonist with Ki of 0.7 nM/0.12 nM in binding and functional assays respectively; has low affinity (Ki=7600 nM) for human CB2 receptors; reverses cannabinoid agonist mediated responses, reduces food intake, and increases energy expenditure and fat oxidation in rodents.ObesityPhase 3 Discontinued

  • GW 833972A

    GW 833972A is a selective CB2 receptor agonist that inhibits induced neural depolarization and citric acid-induced cough in an animal model.

  • Anandamide

    Anandamide, an immune modulator, acts via not only cannabinoid receptors (CB1 and CB2) but also other targets (e.g., GPR18/GPR55) in the central nervous system.